Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,893.90
-26.60 (-1.39%)
Jul 18, 2025, 3:29 PM IST
Concord Biotech Revenue
In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B INR with 18.01% growth. Concord Biotech had revenue of 4.30B in the quarter ending March 31, 2025, with 34.77% growth.
Revenue
12.00B
Revenue Growth
+18.01%
P/S Ratio
16.51
Revenue / Employee
8.72M
Employees
1,377
Market Cap
198.13B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |